{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:04:15Z","timestamp":1774861455445,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Finding new uses for existing drugs, known as drug repurposing, is a widely adopted drug development strategy in the pharmaceutical industry. Computational drug repurposing leverages vast biomedical data to prioritize repurposing candidates. Once these candidates are prioritized, domain experts face the burden of evaluating their true potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this work, we propose a visualization-based approach to address this challenge for a multimodal class of computational drug repurposing, where heterogeneous evidence modalities are integrated. We conducted a design study in close collaboration with domain experts, from which we derived a domain abstraction of the expert assessment process. Grounded in this abstraction, we developed an interactive visualization approach that explicitly models the expert reasoning process. We applied the proposed approach to create a prototype implementation, molIEreVIS, in the context of an operational drug repurposing pipeline. We used this prototype to collect qualitative feedback from domain experts actively engaged in assessing computational drug repurposing candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results demonstrate the potential of our approach to support insights and reasoning in this process and reveal directions for enhancements and future work.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbinf.2026.1756459","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:15:32Z","timestamp":1774858532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["molIEreVIS: exploring and interpreting the evidence behind drug repurposing predictions"],"prefix":"10.3389","volume":"6","author":[{"given":"Amal","family":"Alnouri","sequence":"first","affiliation":[{"name":"Visual Data Science Lab, Johannes Kepler University","place":["Linz, Austria"]}]},{"given":"Andreas","family":"Hinterreiter","sequence":"additional","affiliation":[{"name":"Visual Data Science Lab, Johannes Kepler University","place":["Linz, Austria"]}]},{"given":"Christian","family":"Steinparz","sequence":"additional","affiliation":[{"name":"Visual Data Science Lab, Johannes Kepler University","place":["Linz, Austria"]}]},{"given":"Labinot","family":"Bajraktari","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim RCV GmbH & Co KG","place":["Vienna, Austria"]}]},{"given":"Sebastian","family":"Burgstaller-Muehlbacher","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co KG","place":["Biberach, Germany"]}]},{"given":"Markus","family":"Bauer","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim RCV GmbH & Co KG","place":["Vienna, Austria"]}]},{"given":"Gregorio","family":"Alanis-Lobato","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co KG","place":["Biberach, Germany"]}]},{"given":"Marc","family":"Streit","sequence":"additional","affiliation":[{"name":"Visual Data Science Lab, Johannes Kepler University","place":["Linz, Austria"]}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109158","DOI":"10.1016\/j.compbiomed.2024.109158","article-title":"Identifying indications for novel drugs using electronic health records","volume":"183","author":"Adamek","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Reviews Drug Discovery"},{"key":"B3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/bib\/bbw110","article-title":"A review of validation strategies for computational drug repositioning","volume":"19","author":"Brown","year":"2018","journal-title":"Briefings Bioinformatics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/bcp.13851","article-title":"Using human experience to identify drug repurposing opportunities: theory and practice","volume":"85","author":"Cavalla","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41597-023-01960-3","article-title":"Building a knowledge graph to enable precision medicine","volume":"10","author":"Chandak","year":"2023","journal-title":"Sci. Data"},{"key":"B6","article-title":"End-to-end chart summarization via visual chain-of-thought in vision-language models","author":"Choi","year":"2025"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-biodatasci-110123-025333","article-title":"Computational approaches to drug repurposing: methods, challenges, and opportunities","volume":"7","author":"Cousins","year":"2024","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.crbiot.2022.02.004","article-title":"Big data: historic advances and emerging trends in biomedical research","volume":"4","author":"Cremin","year":"2022","journal-title":"Curr. Res. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1109\/TVCG.2013.173","article-title":"Lineup: visual analysis of multi-attribute rankings","volume":"19","author":"Gratzl","year":"2013","journal-title":"IEEE Transactions Visualization Computer Graphics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"814093","DOI":"10.3389\/fgene.2022.814093","article-title":"Knowledge graphs for indication expansion: an explainable target-disease prediction method","volume":"13","author":"Gurbuz","year":"2022","journal-title":"Front. Genetics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/molecules29030635","article-title":"Drug repurposing in the chemotherapy of infectious diseases","volume":"29","author":"Hamid","year":"2024","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jbi.2017.08.011","article-title":"Literature based discovery: models, methods, and trends","volume":"74","author":"Henry","year":"2017","journal-title":"J. Biomedical Informatics"},{"key":"B13","volume-title":"Drug discovery and development: technology in transition","author":"Hill","year":"2021"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1038\/s41591-024-03233-x","article-title":"A foundation model for clinician-centered drug repurposing","volume":"30","author":"Huang","year":"2024","journal-title":"Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"123814","DOI":"10.1016\/j.lfs.2025.123814","article-title":"Integrative machine learning and structure-based drug repurposing for identifying potent inhibitors of human syk activity against cancer","volume":"378","author":"Iqbal","year":"2025","journal-title":"Life Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/proteomes11040034","article-title":"Multi-omics integration for the design of novel therapies and the identification of novel biomarkers","volume":"11","author":"Ivanisevic","year":"2023","journal-title":"Proteomes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13321-020-00450-7","article-title":"A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Jarada","year":"2020","journal-title":"J. Cheminformatics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/TVCG.2025.3633887","article-title":"Hypochainer: a collaborative system combining llms and knowledge graphs for hypothesis-driven scientific discovery","volume":"32","author":"Jiang","year":"2025","journal-title":"IEEE Trans. Vis. Comput. Graph."},{"key":"B19","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1038\/s41598-024-67163-x","article-title":"Explainable drug repurposing via path based knowledge graph completion","volume":"14","author":"Jim\u00e9nez","year":"2024","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fphar.2025.1619639","article-title":"In silico repurposing of fda-approved drugs against MEK1: structural and dynamic insights into lung cancer therapeutics","author":"Khan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ. Journal Bioorganic Chemistry"},{"key":"B22","article-title":"RepoLLM: a multi-modal foundation model for drug repurposing via alignment of molecules, EHRs, and knowledge graphs","volume-title":"ICML 2025 workshop on multi-modal foundation models and large language models for life sciences","author":"Li","year":"2025"},{"key":"B23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.drudis.2012.08.005","article-title":"In silico drug repositioning\u2013what we need to know","volume":"18","author":"Liu","year":"2013","journal-title":"Drug Discovery Today"},{"key":"B24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/genes10030238","article-title":"Challenges in the integration of omics and non-omics data","volume":"10","author":"L\u00f3pez de Maturana","year":"2019","journal-title":"Genes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1038\/s41598-024-67594-6","article-title":"In silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy","volume":"14","author":"Lv","year":"2024","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"272508","DOI":"10.3389\/fphar.2017.00298","article-title":"On the integration of in silico drug design methods for drug repurposing","volume":"8","author":"March-Vila","year":"2017","journal-title":"Front. Pharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-biodatasci-102523-103838","article-title":"Human genetics and genomics for drug target identification and prioritization: open targets\u2019 perspective","volume":"7","author":"McDonagh","year":"2024","journal-title":"Annu. Review Biomedical Data Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"31461","DOI":"10.1038\/s41598-024-82967-7","article-title":"Repurposing fda-approved drugs targeting fzd10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation","volume":"14","author":"Ngernsombat","year":"2024","journal-title":"Sci. Reports"},{"key":"B29","volume-title":"Usability 101: introduction to usability","author":"Nielsen","year":"2012"},{"key":"B30","doi-asserted-by":"publisher","first-page":"jjaf137","DOI":"10.1093\/ecco-jcc\/jjaf137","article-title":"Drug repurposing approach for the discovery of therapeutic agents for crohn\u2019s disease-associated intestinal fibrosis","volume":"19","author":"Nikolakis","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B31","article-title":"Drug repurposing hypothesis validation with knowledge-infused explanations","volume-title":"CEUR workshop proceedings (CEUR-WS)","author":"Nunes","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/jamiaopen\/ooaa048","article-title":"Framework for identifying drug repurposing candidates from observational healthcare data","volume":"3","author":"Ozery-Flato","year":"2020","journal-title":"Jamia Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.csbj.2020.04.004","article-title":"Drug repositioning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs","volume":"18","author":"Parisi","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/cgf.12883","article-title":"Pathfinder: visual analysis of paths in graphs","volume":"35","author":"Partl","year":"2016","journal-title":"Comput. Graph. Forum"},{"key":"B35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.17615\/dmfd-x198","article-title":"Validation approaches for computational drug repurposing: a review","volume":"2023","author":"Pillai","year":"2024","journal-title":"AMIA Annu. Symp. Proc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1460100","DOI":"10.3389\/fddsv.2024.1460100","article-title":"How drug repurposing can advance drug discovery: challenges and opportunities","volume":"4","author":"Pinzi","year":"2024","journal-title":"Front. Drug Discov."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.3390\/app15168785","article-title":"A hybrid approach to literature-based discovery: combining traditional methods with llms","volume":"15","author":"Preiss","year":"2025","journal-title":"Appl. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Reviews Drug Discovery"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1016\/j.csbj.2021.08.003","article-title":"A data-driven methodology towards evaluating the potential of drug repurposing hypotheses","volume":"19","author":"Santamar\u00eda","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/picr.picr_70_24","article-title":"Drug repurposing: clinical practices and regulatory pathways","volume":"16","author":"Saranraj","year":"2025","journal-title":"Perspect. Clin. Res."},{"key":"B41","first-page":"3709","article-title":"Explaining drug-discovery hypotheses using knowledge-graph patterns","author":"Schatz","year":"2021"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1101\/2025.02.18.25321035","article-title":"Genomics-informed drug repurposing strategy identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease","author":"Seagle","year":"2025"},{"key":"B43","doi-asserted-by":"publisher","first-page":"D704","DOI":"10.1093\/nar\/gkz997","article-title":"The monarch initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species","volume":"48","author":"Shefchek","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"103218","DOI":"10.1016\/j.artmed.2025.103218","article-title":"Ai-based mining of biomedical literature: applications for drug repurposing for the treatment of dementia","volume":"168","author":"Sikirzhytskaya","year":"2025","journal-title":"Artif. Intell. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","article-title":"Multimodal data fusion for cancer biomarker discovery with deep learning","volume":"5","author":"Steyaert","year":"2023","journal-title":"Nat. Machine Intelligence"},{"key":"B46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12967-024-06046-1","article-title":"Reversal gene expression assessment for drug repurposing, a case study of glioblastoma","volume":"23","author":"Sun","year":"2025","journal-title":"J. Transl. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41573-025-01164-x","article-title":"Computational drug repurposing: approaches, evaluation of in silico resources and case studies","volume":"24","author":"Tanoli","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.36948\/ijfmr.2024.v06i06.31585","article-title":"Drug repurposing and its various approaches","volume":"6","author":"Thakur","year":"2024","journal-title":"Int. J. For Multidiscip. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"eadj3010","DOI":"10.1126\/sciadv.adj3010","article-title":"Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking","volume":"10","author":"Thorman","year":"2024","journal-title":"Sci. Adv."},{"key":"B50","volume-title":"Medical subject headings (mesh)","year":"2025"},{"key":"B51","first-page":"5","article-title":"Interactive visual explanations for deep drug repurposing","author":"Wang","year":"2021"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1109\/TVCG.2022.3209435","article-title":"Extending the nested model for user-centric xai: a design study on gnn-based drug repurposing","volume":"29","author":"Wang","year":"2022","journal-title":"IEEE Trans. Vis. Comput. Graph."},{"key":"B53","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"Drugbank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Research"},{"key":"B54","article-title":"Chartadapter: large vision-language model for chart summarization","author":"Xu","year":"2024"},{"key":"B55","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/13872877251344572","article-title":"Therapeutic targets for alzheimer\u2019s disease: proteome-wide mendelian randomization and colocalization analyses","volume":"106","author":"Yu","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1038\/s41467-023-43929-1","article-title":"High-throughput target trial emulation for alzheimer\u2019s disease drug repurposing with real-world data","volume":"14","author":"Zang","year":"2023","journal-title":"Nat. Communications"},{"key":"B57","doi-asserted-by":"publisher","first-page":"102327","DOI":"10.1016\/j.sbi.2021.102327","article-title":"Graph neural network approaches for drug-target interactions","volume":"73","author":"Zhang","year":"2022","journal-title":"Curr. Opin. Struct. Biol."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2026.1756459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:15:41Z","timestamp":1774858541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2026.1756459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":57,"alternative-id":["10.3389\/fbinf.2026.1756459"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2026.1756459","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1756459"}}